Vigil Neuroscience (VIGL)
Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring t...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 8.050
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- prnewswire · Feb 26 at 12:53 PM
07:53 ETBioVigil's Automated Hand Hygiene Monitoring Drives Meaningful and Sustained HAI Reduction
- prnewswire · Feb 5 at 01:37 PM
08:36 ETSonorous Neurovascular Receives FDA Breakthrough Device Designation for BosSTENT™, First Braided Self-Expanding Cerebral Venous Stent, to Treat Debilitating Pulsatile Tinnitus
- TradingView · Nov 18, 2025 at 02:03 AM
Key facts: Sanofi acquires Vigil Neuroscience for $470 million; Formycon shares rise 8%
- Tip Ranks · Aug 7, 2025 at 04:57 PM
Sanofi Finalizes Acquisition of Vigil Neuroscience to Boost Neurology Pipeline
